/C O R R E C T I O N -- Rosetta Gen... (ess highlights. The 2008 first-quarte...)

/C O R R E C T I O N -- Rosetta Genomics Ltd/

Date:5/21/2008

ess highlights.

The 2008 first-quarter net loss of $3.9 million (including a non-cash expense of $191,000 related to stock based compensation), or $0.33 per ordinary share. The first-quarter result compares with a net loss of $2 million (including a non-cash expense of $205,000 related to stock based compensation), or $0.23 per ordinary share, for the corresponding quarter of 2007.

"This has been a remarkable quarter for us at Rosetta Genomics on both the business and scientific fronts," said Amir Avniel, President and CEO of Rosetta Genomics. "We have continued the rapid advancements towards the launch of the first diagnostic tests based on our microRNA technology, and look forward to the exciting events that lay ahead of us in the following months."

On the business front, Rosetta Genomics recently announced that Columbia University Medical Center's Molecular Pathology Laboratory has submitted the first microRNA-based test based on the company's microRNA technology for regulatory approval to the New York State Department of Health. The test is designed to differentiate squamous from non squamous non-small cell lung cancer (NSCLC) and is the first of three tests the company expects will be submitted for regulatory approval by CLIA certified labs in 2008.

In addition, the company recently announced an agreement with the University of California, Irvine School of Medicine to develop diagnostic tests based on Rosetta's proprietary microRNA technology.

On the scientific front, in a paper published in the April issue of Nature Biotechnology, Rosetta Genomics and collaborators demonstrated the significant potential of microRNAs to be used as biomarkers for diagnosing the primary tumor site in patients with cancer of unknown primary (CUP). The company expects a CUP test based on its microRNA technology to be submitted for regulatory approval by a CLIA certified lab by the end of 2008.

Financial Overview

Operating loss for th
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Related biology technology :

1. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
2. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
3. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
4. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
5. Rosetta Genomics to Host and Webcast its R&D Day on Friday, October 26, 2007
6. Rosetta Genomics Will Host and Webcast its R&D Day on Friday, October 26, 2007
7. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
8. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
9. Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-based Diagnostics for Leukemia and Non Hodgkin Lymphoma
10. Rosetta Genomics Announces Initiation of Expansion of US Operations to Facilitate Expected Product Launches in 2008
11. Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer

Post Your Comments:

(Date:5/21/2013)... a new study led by George Washington University ... nucleation of ice in small droplets is strongly ... at the nanoscale. The formation of ice at ... question whose answer also has important implications for ... crystallization of ice from supercooled water is generally ...

(Date:5/21/2013)... 2013 Clinverse, Inc. , ... clinical trials, announced today it has formed a ... Clinverse’s ClinPay® FLS eClinical commerce platform aggregates data ... SpendMD ™, Aggregate Spend Solutions’ recently-launched flagship ... and reporting transfer of value at investigator meetings ...

(Date:5/21/2013)... Many have long discussed the link between mental ... from Clinical Psychiatry.com readdressed the topic of ... suggested using hypnotherapy and other mental health ... that cause acne. , Doctors in the article mentioned ... stress causes changes in the skin that have been ...

(Date:5/21/2013)... , May 21, 2013 Personal Genome ... use its proprietary methodologies and expertise in genomic ... kinase targets in collaboration with Blueprint Medicines. PGDx ... at identifying genomic alterations in tumors, and Blueprint ... kinase inhibitors for a genetically defined patient population. ...

Breaking Biology Technology:Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2 Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2 Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3 Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2 Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2 Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3

[0] Study led by GW professor provides better understanding of water's freezing behavior at nanoscale [0] Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC [0] Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions [0] Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets

... ... ... ... ...

... ... antibody designed to block signaling of ErbB3. This is the first of multiple trials that ... clinical development program for MM-121. , ... Cambridge, Mass. (PRWEB) February 22, 2010 -- Merrimack Pharmaceuticals, Inc. announced today that the ...

Cached Biology Technology:Savient to Present at the Cowen and Company 30th Annual Health Care Conference 2 The University of Amsterdam Joins the MetaMiner Metabolic Diseases Project 2 The University of Amsterdam Joins the MetaMiner Metabolic Diseases Project 3 The University of Amsterdam Joins the MetaMiner Metabolic Diseases Project 4 Merrimack Pharmaceuticals Initiates Enrollment in Phase 1/2 Combination Study of MM-121 and Tarceva in Patients with Non-Small Cell Lung Cancer 2 Merrimack Pharmaceuticals Initiates Enrollment in Phase 1/2 Combination Study of MM-121 and Tarceva in Patients with Non-Small Cell Lung Cancer 3

Savient to Present at the Cowen and Company 30th Annual Health Care Conference The University of Amsterdam Joins the MetaMiner Metabolic Diseases Project Merrimack Pharmaceuticals Initiates Enrollment in Phase 1/2 Combination Study of MM-121 and Tarceva in Patients with Non-Small Cell Lung Cancer

(Date:5/20/2013)... USA New Geology articles posted ... 2013 cover a wide swath of geoscience subdisciplines, ... geophysics, and paleobotany. Locations studied include Siberia; the ... Alpi Apuane, Italy; Ukraine; Mars; and the Southeastern ... 1. Rubies, jadeite, and plate tectonics;, 2. The ...

(Date:5/18/2013)... (May 18, 2013) Research presented today at Digestive ... research, with findings about the impact of coffee on ... , While coffee consumption recently has been associated with ... even a few more cups of java each month ... liver disease. Researchers at the Mayo Clinic, Rochester, MN, ...

(Date:5/17/2013)... Jersey, and City University of New York have invented ... effectively clears organisms to be viewed under microscopes. Visikol ... is one of the few high-quality clearing solutions currently ... Enforcement Administration (DEA) due to its use as a ... for viewing organisms under a microscope. Without them, microscope ...

[0] New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More [0] Coffee consumption associated with reduced risk of autoimmune liver disease [0] New formula invented for microscope viewing, substitutes for federally controlled drug

... sponge-like material that is black, brittle and freeze-dried (just ... some pretty impressive feats. Designed by Northwestern University chemists, ... hydrogen from other gases and, perhaps most impressive of ... currently used to pull sulfur out of crude oil. ...

... SAN DIEGOExposure to particulate matter has been recognized as ... time, but a new study indicates inhalation of certain ... affecting both the development and the outcome of cancers ... Sunday, May 17, at the 105th International Conference of ...

... 2009 GenWay Biotech, Inc., ( www.genwaybio.com ) a ... antibody solutions, announced its partnership with AMDL, Inc., a ... the distribution of AMDL,s DR-70 (FDP) cancer test in ... will be the exclusive distributor of the DR-70 test ...

Cached Biology News:One sponge-like material, three different applications 2 One sponge-like material, three different applications 3 Environmental exposures may damage DNA in as few as three days 2 GenWay Biotech obtains exclusive rights to AMDL's DR-70 cancer test in US and Canada 2

One sponge-like material, three different applications Environmental exposures may damage DNA in as few as three days GenWay Biotech obtains exclusive rights to AMDL's DR-70 cancer test in US and Canada

... F10 tubing kit provides high-pressure tubing ... system and other chromatography systems. The ... Tefzel, and orange PEEK tubing for ... basic chromatography system running at flow ...

... thermal cycler holds 96 x 0.2 ml ... heated lid incorporates a thumbwheel to adjust ... vessels for oil-free cycling. Peltier heat pumps ... and ramping rates of up to 1.4 ...

... thermocycler provides maximum performance on minimum space. ... elements, high heating and cooling rates have ... times. With a maximum capacity of 48 ... the capacity of much more expensive 96 ...

Dual-bay Dyad thermal cycler chassis, does not include the Alpha units (requires 2)...

Biology Products:

F10 Tubing Kit from Bio-Rad PTC-100 Thermal Cycler With Hot Bonnet Heated Lid, 96-well from Bio-Rad Tpersonal Combi from LABREPCO, Inc.Dual-bay Dyad thermal cycler chassis from Bio-Rad